Albumin BCG2— 510(k) K203248

Substantially Equivalent

Abbott Ireland Diagnostics Division

FDA 510(k) clearance K203248 for Albumin BCG2, Substantially Equivalent on 2021-11-23. Applicant: Abbott Ireland Diagnostics Division.

Clearance details

Applicant: Abbott Ireland Diagnostics Division
Product code: Code CIX
Advisory panel: Clinical Chemistry
Date received: 2020-11-04
Decision date: 2021-11-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Longford, IE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.